BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23596055)

  • 1. Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV-positive and HPV-negative locally advanced squamous cell carcinoma of the oropharynx.
    Dobrosotskaya IY; Bellile E; Spector ME; Kumar B; Feng F; Eisbruch A; Wolf GT; Prince ME; Moyer JS; Teknos T; Chepeha DB; Walline HM; McHugh JB; Cordell KG; Ward PD; Byrd S; Maxwell JH; Urba S; Bradford CR; Carey TE; Worden FP
    Head Neck; 2014 May; 36(5):617-23. PubMed ID: 23596055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.
    Worden FP; Kumar B; Lee JS; Wolf GT; Cordell KG; Taylor JM; Urba SG; Eisbruch A; Teknos TN; Chepeha DB; Prince ME; Tsien CI; D'Silva NJ; Yang K; Kurnit DM; Mason HL; Miller TH; Wallace NE; Bradford CR; Carey TE
    J Clin Oncol; 2008 Jul; 26(19):3138-46. PubMed ID: 18474879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study.
    Chen AM; Felix C; Wang PC; Hsu S; Basehart V; Garst J; Beron P; Wong D; Rosove MH; Rao S; Melanson H; Kim E; Palmer D; Qi L; Kelly K; Steinberg ML; Kupelian PA; Daly ME
    Lancet Oncol; 2017 Jun; 18(6):803-811. PubMed ID: 28434660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly paclitaxel and carboplatin combination chemotherapy in patients with advanced squamous cell carcinoma of the head and neck.
    Moosmann P; Egli F; Stahel RA; Jost L
    Onkologie; 2003 Dec; 26(6):568-72. PubMed ID: 14709932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
    Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
    J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 1 study of nab-paclitaxel, cisplatin and 5-fluorouracil as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the oropharynx.
    Loong HH; Winquist E; Waldron J; Chen EX; Kim J; Palma D; Read N; Razak AR; Diaz-Padilla I; Chan K; Bayley A; Hossain M; Wang L; Chin S; Siu LL; Hope A
    Eur J Cancer; 2014 Sep; 50(13):2263-70. PubMed ID: 24953566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concurrent chemoradiotherapy for squamous cell carcinoma of the oropharynx].
    Kubota A; Furukawa M; Hanamura H; Fujita Y; Sugiyama M
    Nihon Jibiinkoka Gakkai Kaiho; 2007 Sep; 110(9):635-42. PubMed ID: 17966498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.
    Shirinian MH; Weber RS; Lippman SM; Dimery IW; Earley CL; Garden AS; Michaelson J; Morrison WH; Kramer A; Byers R
    Head Neck; 1994; 16(1):39-44. PubMed ID: 7510276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of body mass index on chemoradiation outcomes in head and neck cancer.
    McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB
    Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and oncological results of non-surgical vs surgical treatment in squamous cell carcinomas of the oropharynx.
    Díaz-Molina JP; Rodrigo JP; Alvarez-Marcos C; Blay P; de la Rúa A; Estrada E; Alonso R
    Acta Otorrinolaringol Esp; 2012; 63(5):348-54. PubMed ID: 22503508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent chemoradiation with carboplatin-5-fluorouracil versus cisplatin in locally advanced oropharyngeal cancers: is more always better?
    Barkati M; Fortin B; Soulières D; Clavel S; Després P; Charpentier D; Tabet JC; Guertin L; Olivier MJ; Coulombe G; Donath D; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):410-6. PubMed ID: 19427745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.
    Cmelak AJ; Murphy BA; Burkey B; Douglas S; Shyr Y; Netterville J
    Head Neck; 2007 Apr; 29(4):315-24. PubMed ID: 17252600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review.
    Winquist E; Agbassi C; Meyers BM; Yoo J; Chan KKW;
    J Otolaryngol Head Neck Surg; 2017 Apr; 46(1):29. PubMed ID: 28376866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly low-dose docetaxel-based chemoradiotherapy for locally advanced oropharyngeal or hypopharyngeal carcinoma: a retrospective, single-institution study.
    Fukada J; Shigematsu N; Takeda A; Ohashi T; Tomita T; Shiotani A; Kunieda E; Kawaguchi O; Fujii M; Kubo A
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):417-24. PubMed ID: 19409727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin superior to carboplatin in adjuvant radiochemotherapy for locally advanced cancers of the oropharynx and oral cavity.
    Rades D; Ulbricht T; Hakim SG; Schild SE
    Strahlenther Onkol; 2012 Jan; 188(1):42-8. PubMed ID: 22194029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
    Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
    Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
    Bhayani MK; Hutcheson KA; Barringer DA; Lisec A; Alvarez CP; Roberts DB; Lai SY; Lewin JS
    Head Neck; 2013 Nov; 35(11):1634-40. PubMed ID: 23322563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
    Mantz CA; Vokes EE; Stenson K; Kies MS; Mittal B; Witt ME; List MA; Weichselbaum RR; Haraf DJ
    Cancer J; 2001; 7(2):140-8. PubMed ID: 11324767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.